Study summary

The purpose of this study is to evaluate efficacy and safety of ASP8232 in subjects with diabetic macular edema (DME). This study will evaluate the percent change from baseline in excess central subfield thickness (CST) in the study eye as assessed by spectral domain-optical coherence Tomography (SD-OCT) for ASP8232 monotherapy at Month 3.

Additional Study Details

Phase
2
Product
N/A
Product
ASP8232
ranibizumab
Placebo
Type
Interventional
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Enrollment number
96
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects with Diabetic Macular Edema (DME)? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site US10021
    Phoenix, AZ, United States, 85104
    Completed
    Site US10012
    Nashville, TN, United States, 37203
    Completed
    Site US10013
    Houston, TX, United States, 77030
    Completed
    Site US10031
    Santa Ana, CA, United States, 92705
    Completed
    Site US10036
    Augusta, GA, United States, 30909
    Completed
    Site US10009
    San Antonio, TX, United States, 78240-1502
    Withdrawn
    Site US10022
    Lynbrook, NY, United States, 11563
    Completed
    Site US10007
    Palm Desert, CA, United States, 92260
    Withdrawn
    Site US10032
    Fort Worth, TX, United States, 76102
    Completed
    Site US10027
    Reno, NV, United States, 89511
    Completed
    Site US10005
    Winter Haven, FL, United States, 33880
    Completed
    Site US10017
    Charlottesville, VA, United States, 22903
    Completed
    Site US10004
    Beverly Hills, CA, United States, 90211
    Completed
    Site US10025
    Tucson, AZ, United States, 85704
    Completed
    Site US10030
    McAllen, TX, United States, 78503
    Completed
    Site US10011
    Sacramento, CA, United States, 95819
    Completed
    Site US10006
    Arcadia, CA, United States, 91007
    Completed
    Site US10010
    Abilene, TX, United States, 79606
    Completed
    Site US10002
    Boston, MA, United States, 02114
    Completed
    Site US10029
    Golden, CO, United States, 80401
    Completed
    Site US10016
    Miami, FL, United States, 33126
    Completed
    Site US10001
    Omaha, NE, United States, 985540
    Completed
    Site US10015
    Austin, TX, United States, 78705

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?